BRIGHTVIEW LLC
NPI 1164205126
Clinic/Center - Methadone in Chesapeake, VA

Q: What is Brightview LLC's NPI number?

The NPI number for Brightview LLC is 1164205126. It was assigned to this organization in the NPPES registry on August 15, 2023.

Q: What is Brightview LLC's specialty?

The primary specialty registered for this NPI is Clinic/Center, specializing in Methadone, with taxonomy code 261QM2800X.

Q: When was this NPI record last updated?

The NPPES record for Brightview LLC was last updated on June 17, 2025. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 13 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.

Active since August 15, 2023CLIA Certified · 3 labs

209 RESEARCH DR STE 102, CHESAPEAKE, VA 23320(833) 510-4357 Get Directions Write a Review

NPPES record last updated: June 17, 2025. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Record update history: Jun 17, 2025, Aug 15, 2023 (2 updates tracked since 2023).

On this page

About Brightview Llc NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

BRIGHTVIEW LLC (NPI 1164205126) is a healthcare organization registered as a methadone in Chesapeake, Virginia and active in the NPI registry since August 2023. The organization holds 3 active CLIA laboratory certificates, maintains 2 additional practice locations, and lists Amy Nieman, Director Payer Enrollment, as its authorized official.

NPPES Registry Identity

NPI1164205126

Entity TypeOrganization

Primary Taxonomy261QM2800X

Legal Business NameBRIGHTVIEW LLC

Location Address209 RESEARCH DR STE 102Chesapeake, VA 23320-5995

Mailing Address4600 Montgomery Rd Ste 400Cincinnati, OH 45212-2600 · (833) 510-4357

Phone(833) 510-4357

Organization SubpartNo

Authorized OfficialAmy NiemanDirector Payer Enrollment · (833) 510-4357

Enumeration DateAugust 15, 2023

Last NPPES UpdateJune 17, 20252 updates tracked since enumeration

NPPES CertifiedJune 17, 2025

✔ NPI 1164205126 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 5

★ Primary SpecialtyClinic/Center · MethadoneAmbulatory Health Care Facilities

Taxonomy Code261QM2800X

Definition

An entity, facility, or distinct part of a facility providing diagnostic, and replacement maintenance treatment services related to individuals with drug addiction.

Also ListedInternal Medicine · Addiction MedicineTaxonomy 207RA0401X

Also ListedCommunity/Behavioral HealthTaxonomy 251S00000X

Also ListedClinic/Center · Rehabilitation, Substance Use DisorderTaxonomy 261QR0405X

Also ListedClinical Medical LaboratoryTaxonomy 291U00000X

209 RESEARCH DR STE 102, Chesapeake, VA 23320

Open in Google Maps ↗

Other Names 1

Doing Business AsBrightview Llc

Secondary Practice Locations 2

Location 19 Oak Branch Dr Ste AGreensboro, NC 27407-2993 · Phone (833) 510-4357

Location 2446 Morgan StCincinnati, OH 45206-2348 · Phone (833) 510-4357

CLIA Laboratory Certificates CMS CLIA 3

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Waiver 49D2279398

Brightview, Llc-Chesapeake North Office · Chesapeake, VA

Active · expires Apr 2, 2027

CLIA Number49D2279398

Laboratory TypePhysician Office

Certificate Effective DateApril 3, 2025

Certificate Expiration DateApril 2, 2027

Laboratory DirectorGilbert Schmidt

Laboratory Phone(502) 724-2507

Laboratory LocationBrightview, Llc-Chesapeake North Office209 Research Drive, Suite 102, Chesapeake, VA 23320

CLIA data matches this NPI record on: Address Name

This certificate is issued to a laboratory to perform only waived tests.

Certificate of Accreditation 36D2119184

Brightview, LLC · Cincinnati, OH

Active · expires Sep 11, 2026

CLIA Number36D2119184

Laboratory TypePhysician Office

Certificate Effective DateSeptember 12, 2024

Certificate Expiration DateSeptember 11, 2026

Laboratory DirectorDr. Tiffany Flowers

Laboratory Phone(859) 912-0191

Laboratory LocationBrightview, LLC446 Morgan Street, Cincinnati, OH 45206

CLIA data matches this NPI record on: Address Name

This is a certificate that is issued to a laboratory on the basis of the laboratory's accreditation by an accreditation organization approved by CMS.

Certificate of Waiver 49D2279401

Brightview, Llc-Chesapeake South Office · Chesapeake, VA

Active · expires Apr 2, 2027

CLIA Number49D2279401

Laboratory TypePhysician Office

Certificate Effective DateApril 3, 2025

Certificate Expiration DateApril 2, 2027

Laboratory DirectorGilbert Schmidt

Laboratory Phone(502) 724-2507

Laboratory LocationBrightview, Llc-Chesapeake South Office516 Innovation Drive, Suite 102, Chesapeake, VA 23320

CLIA data matches this NPI record on: Name

This certificate is issued to a laboratory to perform only waived tests.

Areas of Expertise CMS Part B claims 4

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for G2077

Periodic assessment is a routine check-up by trained professionals to determine the best mix of services and treatments for your health needs. This is typically provided by a Medicare-enrolled opioid treatment program. It's listed separately in addition to your main treatment code. This ensures you receive the most suitable care for your situation.

239 services29 patients

Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm G2067

Medication Assisted Treatment (MAT) with methadone is a comprehensive approach to manage opioid addiction. It includes weekly methadone dispensing, substance use counseling, individual and group therapy sessions, and toxicology tests as needed, all provided by a Medicare-enrolled opioid treatment program.

191 services11 patients

Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opi G2068

Medication Assisted Treatment (MAT) is a comprehensive approach to managing opioid addiction. It includes a weekly program of buprenorphine medication, personal and group therapy, substance use counseling, and, if necessary, toxicology testing. This service is provided by a Medicare-enrolled opioid treatment provider.

149 services20 patients

Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure G2079

Buprenorphine is a medication used to treat opioid addiction. A Medicare-enrolled opioid treatment program may provide a take-home supply for up to 7 additional days. This service is listed separately from the primary procedure and is part of your comprehensive treatment plan.

149 services13 patients

Leave this field empty

Other Providers at the Same Location NPPES 12

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

KIM SPEAKS RN

Registered Nurse